Arcutis Biotherapeutics, Inc.
Ticker: 1787306
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 129.86+23.2% | 105.40+6.2% | 99.22+21.7% | 81.50+23.8% | 65.85+47.1% | 44.76+45.0% | 30.86-37.7% | 49.57 |
| Total Income | 129.86+23.2% | 105.40+6.2% | 99.22+21.7% | 81.50+23.8% | 65.85+47.1% | 44.76+45.0% | 30.86-37.7% | 49.57 |
| EXPENSES | ||||||||
| Expenditure | 113.43-0.9% | 114.49+26.2% | 90.69-5.6% | 96.12+6.4% | 90.38+7.8% | 83.82+3.6% | 80.94-0.3% | 81.19 |
| Tax | 0.14+55.6% | 0.09+12.5% | 0.08-76.5% | 0.34+21.4% | 0.28 | 0.00 | 0.00-100.0% | 0.32 |
| PROFIT | ||||||||
| Net Profit | 15.01+232.8% | -11.30-252.5% | 7.41+146.6% | -15.89+36.6% | -25.06+39.7% | -41.54+20.6% | -52.33-47.9% | -35.38 |
| KEY METRICS | ||||||||
| OPM % | 12.65%+21.27pp | -8.62%-17.22pp | 8.59%+26.52pp | -17.93%+19.33pp | -37.25%+50.04pp | -87.29%+12.71pp | -100.00%-36.20pp | -63.79% |
| NPM % | 11.56%+22.27pp | -10.72%-18.19pp | 7.47%+26.96pp | -19.49%+18.57pp | -38.06%+54.75pp | -92.81%+7.19pp | -100.00%-28.62pp | -71.38% |
| EPS | 0.11+222.2% | -0.09-250.0% | 0.06+146.2% | -0.13+35.0% | -0.20+39.4% | -0.33+21.4% | -0.42-31.2% | -0.32 |
Corporate Events
Board MeetingARQT
202631Jul
Board Meeting
C-suite transition: L. Todd Edwards resigns as Chief Commerc…
SEC Filing ↗ Board MeetingARQT
202615Jul
Board Meeting
Christopher Peetz appointed to the Board of Directors Chris…
SEC Filing ↗ Board MeetingARQT
20265Jun
Board Meeting
2026 Annual Meeting of Stockholders where three Class III di…
SEC Filing ↗